Skip to content
healthcare.dev

YESAFILI

NDC 83257-035, aflibercept-jbvf, injection, solution, from Biocon Biologics Inc..

Product NDC
83257-035
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761274
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AFLIBERCEPT2 mg/.05mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
83257-035-41832570035411 SYRINGE, GLASS in 1 CARTON (83257-035-41) / .05 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7d69a7b0-9511-c030-3b85-13b23f9d2980

Use it

Look up 83257-035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.